Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

12.91

+0.26 (2.06%)

At close: Jan 29, 2026, 4:00 PM EST

12.90

-0.01 (-0.08%)

After-hours: Jan 29, 2026, 4:04 PM EST

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 29, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2016 - 2020
Market Capitalization	373	256	220	235	1,075	1,148	Upgrade
Market Cap Growth	249.55%	16.57%	-6.67%	-78.12%	-6.39%	24.98%	Upgrade
Enterprise Value	385	259	173	73	809	784	Upgrade
Last Close Price	12.90	11.97	10.36	11.17	51.87	56.81	Upgrade
PS Ratio	4.21	3.92	3.25	2.97	12.48	11.83	Upgrade
PB Ratio	4.26	3.95	1.70	1.09	3.35	2.88	Upgrade
P/TBV Ratio	5.75	3.95	1.70	1.09	3.35	2.88	Upgrade
EV/Sales Ratio	5.89	3.96	2.56	0.93	9.39	8.08	Upgrade
Debt / Equity Ratio	3.11	3.11	1.76	1.03	0.08	0.02	Upgrade
Asset Turnover	0.20	0.20	0.16	0.19	0.21	0.21	Upgrade
Quick Ratio	4.03	4.03	4.99	6.52	10.00	8.43	Upgrade
Current Ratio	4.21	4.21	5.21	6.73	10.45	8.82	Upgrade
Return on Equity (ROE)	-84.63%	-84.63%	-67.16%	-49.74%	-33.78%	-18.48%	Upgrade
Return on Assets (ROA)	-16.23%	-16.23%	-18.13%	-20.47%	-19.01%	-14.81%	Upgrade
Return on Invested Capital (ROIC)	-107.24%	-92.97%	-138.32%	-163.29%	-94.88%	-91.02%	Upgrade
Return on Capital Employed (ROCE)	-36.80%	-36.80%	-38.10%	-34.30%	-35.80%	-27.20%	Upgrade
Earnings Yield	-21.99%	-32.00%	-52.86%	-56.90%	-11.33%	-6.88%	Upgrade
FCF Yield	-8.64%	-12.57%	-44.06%	-47.71%	-8.08%	-6.16%	Upgrade
Buyback Yield / Dilution	-0.85%	-0.85%	-0.90%	-1.78%	-2.14%	-1.16%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q